Improving Care of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Female doctor consulting senior male patient both looking at ipadParticipation in activities of daily life can be challenging for those with transthyretin amyloid cardiomyopathy (ATTR-CM), a restrictive cardiomyopathy produced by extracellular deposition of transthyretin. Geographic and racial healthcare disparities add to the burden of disease. Shared decision making and early detection with readily available noninvasive tests, among other strategies, are essential as therapy for ATTR-CM.

Videos On Demand

Developing an Amyloidosis Center of Excellence: Path to Success and Overcoming Challenges
This is the third and final webinar in the series and discusses steps to develop a center of excellence to provide leadership, best practices, support and/or training of health care professionals within a multidisciplinary team environment to improve the quality of care for cardiac amyloidosis patients as well as challenges that may occur.
Watch On Demand Now
Breaking Down Barriers: Defining and Addressing Healthcare Disparities in ATTR-CM
This is the second webinar in the series. ATTR-CM disproportionately affects black people, a medically underserved population. In this webinar clinicians explore how addressing geographic and racial healthcare disparities can make meaningful differences. Hypertension and other symptoms may confound accurate, timely diagnosis and treatment for many individuals with ATTR-CM. Watch S. Carolina Masri, Kevin Alexander and Nancy Albert discuss practical steps clinicians can take in breaking down barriers for those with ATTR-CM. CE and MOC Credits Available. Approved for 1.0 AAFP Prescribed Credit. Free Webinar.
Watch On Demand Now
Empowering Your Patients to Understand ATTR-CM
In this first of a 3-part series, watch Nancy M. Albert and Katherine E. Di Palo join moderator Kevin Alexander in discussing ways to empower patients to recognize ATTR-CM and share in decision-making about diagnostic and treatment options. CE/ABIM MOC credit available. Approved for 1.0 AAFP Prescribed/Elective credits. Free webinar.
Watch On Demand Now

Recognize the Complexities of Transthyretin Amyloidosis (ATTR amyloidosis)

The clinical presentation of ATTR may be hidden in plain sight. In these continuing education activities explore the varied clinical presentations of amyloidosis in different organ systems including the heart, nervous system, gastro-intestinal tract, and kidneys. Get the facts from an expert panel on how to recognize and treat the complexities of this progressive, degenerative, and multisystemic disorder.

Resources for Clinicians

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Circulation

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association
Circulation

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging
Circulation: Cardiovascular Imaging

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization
Circulation: Cardiovascular Imaging


 

This activity is supported by an independent educational grant from Pfizer.